WHO ICTRP trial

The efficacy of intranasal fentanyl as an adjunct for pain management in…

TCTR20230109003 · Thai Clinical Trials Registry (TCTR) · Not Recruiting

Key facts

Trial ID TCTR20230109003
Public title The efficacy of intranasal fentanyl as an adjunct for pain management in retinopathy of prematurity screening
Scientific title The efficacy of intranasal fentanyl as an adjunct for pain management in retinopathy of prematurity screening
Primary sponsor Bhumibol Adulyadej Hospital
Registry Thai Clinical Trials Registry (TCTR)
Recruitment status Not Recruiting
Study type Interventional
Phase Phase 4
Countries Thailand
Conditions Efficacy of intranasal fentanyl drops as an adjunct for pain management in retinopathy of prematurity screening. Pain, retinopathy of prematurity, intranasal fentanyl;Pain, retinopathy of prematurity, intranasal fentanyl
Interventions Intranasal fentanyl (2 mcg/kg) with normal saline solution until 0.3 ml dropped both nostril prior to retinopathy of prematurity screening 5 minutes.,Intranasal normal saline 0.3 ml;Active Comparator Drug,Placebo Comparator Drug;Intranasal…
Registration date Sep 1, 2023
Target size 22
Secondary IDs Nil Known
Registry page thaiclinicaltrials.org

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations